For individuals battling Transthyretin Amyloid Cardiomyopathy (ATTR-CM), a devastating condition, the introduction of this treatment and Attruby represents a true advancement . These novel therapies stabilize the transthyretin protein, halting its harmful build-up and lessening the burden of the